Show
Sort by
-
The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL
-
Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia
-
USP7 cooperates with NOTCH1 to drive the oncogenic transcriptional program in T-cell leukemia
-
Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia
-
Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
-
Targeting BET family proteins improves the efficacy of ABT-199 in T-cell acute lymphoblastic leukemia
-
The combination of ABT-199 and JQ1 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia
-
Genetic characterization and therapeutic targeting of MYC translocated pediatric T-cell acute lymphoblastic leukemia
-
BRD4 inhibition improves the efficacy of ABT-199 in T-cell acute lymphoblastic leukemia
-
BRD4 inhibition improves the efficacy of ABT-199 in T-cell acute lymphoblastic leukemia